FDA OKs First Drug for Hyperphagia in Prader-Willi Syndrome

(MedPage Today) -- The FDA approved extended-release diazoxide choline (Vykat XR) to treat the intense persistent sensation of hunger in patients 4 years of age and older with Prader-Willi syndrome, maker Soleno Therapeutics announced.
"The FDA...